Takada Shinichiro, Nakashima Hirotaka, Nakayama Keisuke, Uchida Soshi
Department of Orthopedic Surgery, Wakamatsu Hospital of University of Occupational and Environmental and Health, 1-17-1, Hamamachi, Wakamatsu, Kitakyushu-city 808-1264, Fukuoka, Japan.
Biomimetics (Basel). 2025 Jan 18;10(1):65. doi: 10.3390/biomimetics10010065.
While several studies have reported short-term clinical outcomes after medial patellofemoral ligament (MPFL) repair with suture tape augmentation, there is still a dearth of knowledge regarding midterm clinical outcomes. This study aimed to evaluate the midterm clinical outcomes of MPFL repair with suture tape augmentation in patients with patellar dislocation. We retrospectively reviewed the clinical records of patients who underwent MPFL repair with suture tape augmentation for at least one episode of patellar dislocation between 2015 and 2020. Patient-reported clinical outcomes (PROs) were evaluated via the International Knee Documentation Committee (IKDC) score and the knee injury osteoarthritis outcome score (KOOS). In total, 17 knees (4 males and 13 females) who underwent MPFL repair with suture tape augmentation with a mean follow-up of 54.6 ± 19.5 months were included in this study. PROs significantly improved from preoperatively to the final follow-up (IKDC score: 50.7 ± 26.6 vs. 88.8 ± 13.0, < 0.001; KOOS: 68.8 ± 23.3 vs. 91.2 ± 8.4, = 0.011) without reducing the patient's activity level at the final follow-up (UCLA AS score: 7.9 ± 2.4 at preinjury vs. 7.9 ± 2.2 at the final follow-up, = 0.655). Subgroup analysis revealed good postoperative outcomes, regardless of the patient's skeletal maturity or the presence or absence of generalized laxity. In conclusion, MPFL repair with suture tape augmentation is a safe and effective treatment for midterm follow-up.
虽然多项研究报告了使用缝线带增强技术修复内侧髌股韧带(MPFL)后的短期临床结果,但关于中期临床结果的知识仍然匮乏。本研究旨在评估缝线带增强技术修复MPFL治疗髌骨脱位患者的中期临床结果。我们回顾性分析了2015年至2020年间至少有一次髌骨脱位且接受缝线带增强技术修复MPFL的患者的临床记录。通过国际膝关节文献委员会(IKDC)评分和膝关节损伤与骨关节炎疗效评分(KOOS)评估患者报告的临床结果(PROs)。本研究共纳入17例膝关节(4例男性和13例女性),这些患者接受了缝线带增强技术修复MPFL,平均随访时间为54.6±19.5个月。从术前到最终随访,PROs显著改善(IKDC评分:50.7±26.6对88.8±13.0,<0.001;KOOS:68.8±23.3对91.2±8.4,=0.011),且在最终随访时患者的活动水平未降低(加州大学洛杉矶分校活动评分:受伤前为7.9±2.4,最终随访时为7.9±2.2,=0.655)。亚组分析显示,无论患者的骨骼成熟度或是否存在全身松弛,术后结果均良好。总之,缝线带增强技术修复MPFL是一种安全有效的中期随访治疗方法。